Nasdaq:US$15.97 (+1.13) | HKEX:HK$25.02 (+1.62) | AIM:£2.34 (+0.19)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor